JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Boceprevir (previously known as EBP 520; SCH 503034; trade name: Victrelis) is a novel, orally bioavailable, selective, direct acting inhibitor of hepatitis C virus (HCV) protease with Ki value of 14 nM for NS3 in an enzyme assay and EC90 of 350 nM in cell-based replicon assay. It is an FDA approved drug (trade name: Victrelis) used in combination with other antiviral agents for the treatment of chronic hepatitis C, genotype 1. It exerts the effects by binding to the nonstructural 3 NS3 (HCV) active site of HCV.
References: Acc Chem Res. 2008 Jan; 41(1):50-9; Antimicrob Agents Chemother. 2012 Nov; 56(11): 5728–5734.
Related CAS#: 958002-36-3 (HCl)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!